Top Generative AI Companies in Pittsburgh, PA (4)
Build what’s next — with tech that matters PwC provides professional services across Audit and Assurance, Advisory and Tax — powered by a global network of over 370,000 people in 149 countries. You may know us for our business expertise, but technology is core to how we help clients move faster, build trust and deliver meaningful outcomes. As a technologist, you’ll work...
PwC's Top Stability & Growth Strengths
Strong Revenue Growth: Global revenue increased to $60.2B in FY2026, with growth accelerating versus the prior year and all major service lines expanding. Asia Pacific and the Americas contributed most, though expansion was not uniform across regions.
Innovation-Driven Growth: Significant, multi‑billion investments are scaling AI and technology capabilities, alongside large‑scale AI upskilling across the workforce. Initiatives such as AI‑native assurance tools and the PwC One platform indicate a push to embed tech-enabled delivery.
Product Line Growth: New and expanded offerings in technology, consulting, strategy, and tax are being built through acquisitions and strategic investments. Within the latest year, Tax and Legal led growth, with Advisory and Assurance also advancing.
Abridge was founded in 2018 with the mission of powering deeper understanding in healthcare. Our AI-powered platform was purpose-built for medical conversations, improving clinical documentation efficiencies while enabling clinicians to focus on what matters most—their patients. Our enterprise-grade technology transforms patient-clinician conversations into structured clinical notes in real-time, with deep EMR integrations. Powered by Linked Evidence and our purpose-built, auditable AI,...
Abridge AI's Top Stability & Growth Strengths
Investor Backing & Capital Strength: Capital access is described as exceptional, with over $1B in total funding and a valuation rising to $5.3B across successive rounds backed by top‑tier and strategic investors. This depth of financing signals ample runway for R&D and go‑to‑market scale.
Strong Revenue Growth: Revenue momentum is highlighted by contracted ARR of $117M in early 2025 and estimates that actual ARR crossed $100M by mid‑2025, alongside a 4x increase over 18 months. These points indicate rapid monetization of enterprise deployments.
Market Expansion: Enterprise adoption expanded from roughly 100–150 health systems in early/mid‑2025 to more than 250–300 by mid‑2026, including large rollouts at Kaiser Permanente and other marquee systems. Scaling conversation volume from ~50M in 2025 to a projected 80M+ in 2026 underscores a widening footprint.
At Rockfish, we’re helping organizations unlock the full power of their data — making it more usable, more responsible, and more impactful. From testing new products to uncovering hidden insights, our platform empowers teams to move faster, build smarter, and innovate with confidence.We’re not just building technology — we’re shaping how the next generation of companies think about data, privacy,...
We offer solutions that bridge artificial intelligence (AI) and machine learning (ML), physiologically based pharmacokinetics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches. Our technology is licensed and applied by major pharmaceutical, biotechnology, chemical, and consumer goods companies, and regulatory agencies worldwide.







